Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric
JOURNAL OF SURGICAL ONCOLOGY, vol.64, no.4, pp.318-323, 1997 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 64 Issue: 4
- Publication Date: 1997
- Journal Name: JOURNAL OF SURGICAL ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.318-323
- Keywords: etoposide, doxorubicin, cisplatin, chemotherapy, advanced gastric cancer, COOPERATIVE-ONCOLOGY-GROUP, CANCER, CHEMOTHERAPY, TRIAL, ADRIAMYCIN, EAP, ADENOCARCINOMA, CARCINOMA
- Lokman Hekim University Affiliated: No
Abstract
Background: Based on the promising results of EAP (etoposide, doxorubicin, and cisplatin) combination, a phase II study of modified EAP combination was performed in patients with advanced gastric cancer to evaluate the response, toxicity, and survival.